Suppr超能文献

与SARS、MERS相比,严重急性呼吸综合征冠状病毒2(COVID-19)的流行病学和病理生物学:当前知识与未来展望的最新概述

Epidemiology and pathobiology of SARS-CoV-2 (COVID-19) in comparison with SARS, MERS: An updated overview of current knowledge and future perspectives.

作者信息

Ganesh Balasubramanian, Rajakumar Thangarasu, Malathi Mathiyazhakan, Manikandan Natesan, Nagaraj Jaganathasamy, Santhakumar Aridoss, Elangovan Arumugam, Malik Yashpal Singh

机构信息

ICMR-National Institute of Epidemiology (ICMR-NIE), R-127, Second Main Road, TNHB, Ayapakkam, Chennai, 600 077, Tamil Nadu, India.

Indian Veterinary Research Institute (IVRI), Izatnagar, 243 122, Bareilly, Uttar Pradesh, India.

出版信息

Clin Epidemiol Glob Health. 2021 Apr-Jun;10:100694. doi: 10.1016/j.cegh.2020.100694. Epub 2021 Jan 14.

Abstract

Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV-2) is the causative etiology of 'Corona Virus Disease-2019' (COVID-19); formerly referred as 'novel-Coronavirus-2019'. It was originated in Wuhan city, Hubei province, China in early December 2019. The World Health Organization (WHO) declared it as 'Public Health Emergency of International Concern' due to their rapid transmission and causing public and health-care-related casualties worldwide. This review provides an updated overview of COVID-19 (SARS-CoV-2), in comparison with the etiologies of the same group viz. SARS and MERS and also its future perspectives for planning appropriate strategies for prevention, control and treatment modalities to avert similar catastrophe in near future.

摘要

严重急性呼吸综合征冠状病毒2(SARS-CoV-2)是“2019冠状病毒病”(COVID-19)的病原体;以前称为“2019新型冠状病毒”。它于2019年12月初在中国湖北省武汉市出现。世界卫生组织(WHO)因其在全球迅速传播并造成公众和医疗相关伤亡,宣布其为“国际关注的突发公共卫生事件”。本综述提供了COVID-19(SARS-CoV-2)的最新概述,并与同一类病原体即SARS和MERS进行了比较,还探讨了其未来前景,以便制定适当的预防、控制和治疗策略,避免在不久的将来发生类似灾难。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验